Clinical Research Directory
Browse clinical research sites, groups, and studies.
The RESPLASH Study
Sponsor: Tulane University
Summary
To assess the safety and effectiveness of renal artery denervation with subsequent splanchnic nerves denervation via catheter-based radiofrequency ablation in improving blood pressure and glycemic control in patients with resistant hypertension and type 2 diabetes.
Official title: Renal and Splanchnic Sympathetic Denervation as an Alternative Therapy for Resistant Hypertension and Type 2 Diabetes (RESPLASH Study)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-06
Completion Date
2027-06
Last Updated
2026-03-03
Healthy Volunteers
No
Conditions
Interventions
Splanchnic Nerve Denervation
Catheter-based endovascular denervation (CDN) of renal arteries and splanchnic nerves (celiac + SMA) using radiofrequency ablation
Renal Denervation Only
Catheter-based endovascular denervation (CDN) of renal arteries only, without splanchnic nerve denervation
Locations (1)
East Jefferson General Hospital
New Orleans, Louisiana, United States